3,4-methylenedioxyamphetamine has been researched along with Akinetic-Rigid Variant of Huntington Disease in 1 studies
3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ramos, VF | 1 |
1 other study available for 3,4-methylenedioxyamphetamine and Akinetic-Rigid Variant of Huntington Disease
| Article | Year |
|---|---|
Reflections: neurology and the humanities. Love in the time of Huntington's disease.
Topics: Female; Humanities; Humans; Huntington Disease; Love; Male; Neurology; Poetry as Topic | 2010 |